Last reviewed · How we verify
NCT05047978
Growth and Tolerance of a Partially Hydrolyzed Infant Formula
NA trial testing Cow's milk protein infant formula in Growth in 244 participants. Completed in 21 November 2023.
11 October 2022
Quick facts
| Lead sponsor | Mead Johnson Nutrition |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | other |
| Enrollment | 244 |
| Start date | 28 August 2021 |
| Primary completion | 11 October 2022 |
| Estimated completion | 21 November 2023 |
| Sites | 13 locations across United States |
Drugs / interventions tested
- Cow's milk protein infant formula
- Partially hydrolyzed protein infant formula
Conditions studied
- Growth — all drugs for Growth →
Sponsor
Mead Johnson Nutrition — full company profile →
Who can join
Adults 10 Days to 14 Days, any sex, with Growth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research study is to compare the growth and tolerance of infants who consume either an infant formula with intact proteins or an infant formula with partially hydrolyzed proteins through approximately 12 months of age.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05047978
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Growth
Currently open trials in the same condition.
- NCT06018636 — Impact of Diet and Nutrition on Growth and Development in Young Children · recruiting
Other Mead Johnson Nutrition trials
Trials by the same sponsor.
- NCT07513506 — Extensively Hydrolyzed Formula Growth Monitioring Study (GMS) · NA · not yet recruiting
- NCT07498192 — Thai Baby Study Phase 1 · not yet recruiting
- NCT06318117 — Reason for Prescribing Rice Infant Formula · completed
- NCT05744193 — Feeding Study in VLBW Premature Infants · NA · terminated
- NCT05247879 — Clinical Effectiveness and Safety of a Novel Oral Rehydration Solution · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05047978 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mead Johnson Nutrition
- Last refreshed: 23 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05047978.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing